ORIGIO a/s is a world leader in Assisted Reproductive Technology (ART) solutions. Through research and innovation, ORIGIO aims to provide the best products to ART professionals to help the #1 dream of every infertile couple come true. ORIGIO currently comprises the five product families, MediCult Media, Humagen Pipets, MidAtlantic Devices, ORIGIO ScanLab Equipment and Artworks Solutions that cater for the broadest range of ART requirements. The medtech company ORIGIO is headquartered in Måløv, Denmark and has subsidiaries in around 13 countries. In 2012, ORIGIO was acquired by Cooper Surgical, part of US company The Cooper Companies (Ticker: COO). Until 23 August 2012, ORIGIO was listed on the Oslo Stock Exchange (Ticker: ORO).